(PO-147) Descriptive Analysis of Depressive Symptom Severity and Quality of Life in Heart Failure
Background/Significance: Heart Failure (HF) affects more than 26 million adults worldwide. Depressive symptoms in HF patients have a prevalence of at least 48% (Gottlieb 2004). Due to the heightened prevalence of depression in cardiovascular patients, the American Heart Association (AHA) recommends screening patients for depression (Lichman 2008).
Methods: We conducted a descriptive analysis of clinical and demographic characteristics of patients with depression in heart failure patients from our current PCORI-funded trial comparing Antidepressant Medication Management using the Collaborative Care Model to Behavioral Activation Psychotherapy.
Results: Health-related quality of life is significantly impaired in patients with depression and heart failure. Demographic and clinical characteristics predicted HRQoL impairments.
Discussion: Treatment of depression in patients with heart failure need to target not only depressive symptom severity but also health-related quality of life impairments using data available from demographic and clinical predictors.
Conclusion: HRQoL in heart failure patients with depression is severely impaired. C/L psychiatrists are best positioned to provide and guide the provision of evidence-based treatment of depression in heart failure leading to a significant positive impact on HRQoL, and overall health.
The attendees will identify the demographic and clinical characteristics predicting HRQoL impairments in depression and heart failure.